肠易激综合征 (IBS) 治疗市场概览、增长、趋势、分析、研究报告(2020-2028 年)

  • Report Code : TIPRE00006814
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 180
Buy Now

Irritable Bowel Syndrome Treatment Market Analysis by 2021, 28

Buy Now

 

2020 年肠易激综合征 (IBS) 治疗市场价值为 21.5389 亿美元,预计到 2028 年将达到 46.003 亿美元;预计 2021 年至 2028 年的复合年增长率为 10.1%。

肠易激综合征疾病患病率的不断上升和研发活动的不断增加等主要因素推动了市场的增长。然而,产品数量有限和治疗效率低下制约了市场的增长。肠易激综合征是一种影响腹部器官大肠的常见慢性疾病。它也被称为痉挛性结肠、粘液性结肠炎、肠易激综合征和痉挛性结肠炎。这种疾病与炎症性肠病有很大不同。它的症状包括痉挛、腹痛、腹胀、胀气、腹泻或便秘,或两者同时出现。如果症状较轻,可以通过改变压力、生活方式和饮食来控制。另一方面,严重的症状可以通过药物和咨询来治疗。

在亚太地区,已采取多项措施遏制导致 COVID-19 的新型冠状病毒的传播。这些措施扰乱了包括医疗保健行业在内的各个行业许多公司的运营。员工隔离、供应链故障和需求减少给公司带来了严重的麻烦。此外,私立医院连锁店的住院和门诊护理也大幅下降。为了减轻医疗系统的负担,许多诊所推迟了非关键预约。这种情况阻碍了肠易激综合征 (IBS) 治疗的发展。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

肠易激综合征 (IBS) 治疗市场:

肠易激综合征 (IBS) 治疗市场
  • Irritable Bowel Syndrome (IBS) Treatment Market
    复合年增长率(2020 - 2028 年)
    10.1%
  • 2020 年市场规模
    21.5 亿美元
  • 2028 年市场规模
    46 亿美元

市场动态

增长动力
  • 財政部
  • 財政部
  • 財政部
未来的趋势
  • 財政部
  • 財政部
  • 財政部
机会
  • 財政部
  • 財政部
  • 財政部

关键人物;主力;重要一员

  •  
  • Ironwood 制药公司
  • 艾伯维。
  • Sebela 制药公司
  • 武田药品工业株式会社
  • 阿尔法西格玛公司
  • 安斯泰来制药公司
  • 阿斯利康
  • 合成生物制剂公司
  • 博士伦公司

区域概况

Irritable Bowel Syndrome (IBS) Treatment Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Irritable Bowel Syndrome (IBS) Treatment Market类型
  • 腹泻型肠易激综合征
Irritable Bowel Syndrome (IBS) Treatment Market伴有便秘的肠易激综合征
  • 肠易激综合征
Irritable Bowel Syndrome (IBS) Treatment Market混合型肠易激综合征
  • 肠易激综合征
Irritable Bowel Syndrome (IBS) Treatment Market产品
  • 利福昔明
  • 艾卢沙多林
  • 鲁比前列酮
  • 利那洛肽
  • 其他的
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

 

市场洞察

 

肠易激综合征及相关疾病的患病率不断上升

肠易激综合征是一种常见的慢性胃肠道疾病,由排便习惯紊乱和腹痛引起。这种疾病也被称为痉挛性结肠、过敏性结肠、粘液性结肠炎和痉挛性结肠炎。肠易激综合征的症状包括腹痛、便秘、腹泻和痉挛。各地区的卫生系统都见证了肠易激综合征发病率的大幅增长。国际胃肠病基金会发布的数据显示,在所有 IBS 患者中,约 40% 的患者患有轻度 IBS,约 35% 的患者患有中度 IBS,估计 25% 的患者患有重度 IBS。许多人没有意识到 IBS 症状。

某些因素,例如食物过敏、胃肠炎的发展阶段、结肠不规律运动、结肠中血清素的异常成分以及轻度乳糜泻,都是可能导致 IBS 的风险因素。这些因素预计将加速全球 IBS 的患病率。例如,根据 2018 年在 NCBI 上发表的一项研究,估计 IBS 每年影响美国约 10% 至 16% 的人口。如此惊人的 IBS 患病率可能会在预测期内推动肠易激综合征 (IBS) 治疗市场的发展。

基于类型的洞察

根据类型,肠易激综合征 (IBS) 治疗市场细分为混合型 IBS (IBS-M)、腹泻型 IBS (IBS-D) 和便秘型 IBS (IBS-C)。2020 年,混合型 IBS (IBS-M) 细分市场占据了最大的市场份额。此外,预计同一细分市场在预测期内的复合年增长率最高。女性和男性中 IBS 患病率的上升预计将推动对可治疗便秘和腹泻综合症状的药物的需求。老年人口中 IBS 的患病率较高。因此,在预测期内,对治疗混合型 IBS 的药物的需求可能会大幅增长,

基于产品的洞察

根据产品,肠易激综合征 (IBS) 治疗市场细分为利福昔明、依鲁沙多林、鲁比前列酮、利那洛肽等。利那洛肽细分市场在 2020 年占据了最大的市场份额。此外,预计同一细分市场在预测期内的复合年增长率最高。该细分市场的市场增长归因于以下因素:利那洛肽仿制药的制造增加,以及开发和商业化利那洛肽治疗 IBS 的市场整合不断加剧。

 

基于分销渠道的洞察

根据分销渠道,肠易激综合征 (IBS) 治疗市场分为医院药房、药店和零售药店以及在线药店。2020 年,医院药房占据了最大的市场份额。然而,药店和零售药店预计在预测期内将实现最高的复合年增长率。

在肠易激综合征 (IBS) 治疗市场运营的公司采用产品创新战略来满足全球不断变化的客户需求,这也使他们能够在全球市场上保持自己的品牌名称。

 

肠易激综合征治疗市场报告范围

报告属性细节
2020 年市场规模21.5亿美元
2028 年市场规模46亿美元
全球复合年增长率(2020 - 2028)10.1%
历史数据2018-2019
预测期2021-2028
涵盖的领域按类型
  • 腹泻型肠易激综合征
患有便秘的肠易激综合征
  • 肠易激综合征
混合型肠易激综合征
  • 肠易激综合征
按产品
  • 利福昔明
  • 艾卢沙多林
  • 鲁比前列酮
  • 利那洛肽
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • Ironwood 制药公司
  • 艾伯维。
  • Sebela 制药公司
  • 武田药品工业株式会社
  • 阿尔法西格玛公司
  • 安斯泰来制药公司
  • 阿斯利康
  • 合成生物制剂公司
  • 博士伦公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

 

肠易激综合征 (IBS) 治疗市场 – 按类型

  • 腹泻型肠易激综合征 (IBS-D)
  • 伴有便秘的肠易激综合征 (IBS-C)
  • 混合型肠易激综合征 (IBS-M)

 

肠易激综合征 (IBS) 治疗市场 – 按产品分类

  • 利福昔明
  • 艾卢沙多林
  • 利那洛肽
  • 鲁比前列酮
  • 其他的

 

肠易激综合征 (IBS) 治疗市场 – 按分销渠道

  • 医院 药店
  • 药店和零售药店
  • 网上药店

 

肠易激综合征 (IBS) 治疗市场 – 按地区划分

  • 北美

    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲

    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区 (APAC)

    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲 (MEA)

    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • MEA 其他地区
  • 南美洲和中美洲(SCAM)

    • 巴西
    • 阿根廷
    • 其余的骗局

 

公司简介

  • Ironwood 制药公司
  • 艾伯维。
  • Sebela 制药公司
  • 武田药品工业株式会社
  • 阿尔法西格玛公司
  • 安斯泰来制药公司
  • 阿斯利康
  • 合成生物制剂公司
  • 博士伦公司
  • 兰尼特公司
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the major players in the irritable bowel syndrome (IBS) treatment market?

The irritable bowel syndrome (IBS) treatment market majorly consists of the players such as Ironwood Pharmaceuticals, Inc., AbbVie., Sebela Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Alfasigma S.p.A., Astellas Pharma Inc., AstraZeneca, Synthetic Biologics, Inc., Bausch + Lomb Incorporated and Lannett Company Inc amongst others.

What are the driving factors for the irritable bowel syndrome (IBS) treatment market across the globe?

The factors that are driving growth of the market are increasing prevalence of irritable bowel syndrome diseases and increasing research & development activities.

What is irritable bowel syndrome (IBS) treatment?

Irritable bowel syndrome (IBS) is a common disorder that affects the abdominal organ, large intestine. It is also known as spastic colon, mucous colitis, irritable colon, and spastic colitis. The condition is much different than inflammatory bowel disease. However, it is a chronic condition which a person must manage for a longer period. It shows symptoms such as cramping, abdominal pain, bloating, gas, and diarrhea or constipation, or both at the same. These symptoms can be managed by changing stress, lifestyle, and diet. And the more severe symptoms are treated with medication and counseling.

The List of Companies - Irritable Bowel Syndrome (IBS) Treatment Market

  1. Ironwood Pharmaceuticals, Inc.
  2. AbbVie.
  3. Sebela Pharmaceuticals, Inc.
  4. Takeda Pharmaceutical Company Limited
  5. Alfasigma S.p.A.
  6. Astellas Pharma Inc.
  7. AstraZeneca
  8. Synthetic Biologics, Inc.
  9. Bausch + Lomb Incorporated
  10. Lannett Company Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..